25 results
6-K
FMS
Fresenius Medical Care AG
7 May 24
Current report (foreign)
9:20am
to activities in the field of regenerative medicine and products for extracorporeal heart and lung support.
The increase in income from equity method
6-K
FMS
Fresenius Medical Care AG
2 Nov 23
Current report (foreign)
6:09am
in research and development expense was largely driven by lower costs related to activities in the field of regenerative medicine and a positive impact
6-K
FMS
Fresenius Medical Care AG
31 Oct 22
Current report (foreign)
2:39pm
, and in the field of regenerative medicine.
Income from equity method investees decreased by 17% to €17 M from €21 M. The decrease was primarily driven … currency translation and research and development activities at NxStage Medical, Inc., our subsidiary, and in the field of regenerative medicine
6-K
htn54rpvbyufi
2 Nov 21
Current report (foreign)
1:14pm
6-K
fzz6x2osndmjzohnf
30 Jul 21
Current report (foreign)
11:12am
6-K
r7049jfy8
6 May 21
Current report (foreign)
11:17am
6-K
st28zmm7bgw4a
29 Oct 20
Current report (foreign)
12:32pm
6-K
tjaewvv9zg6o46f
30 Jul 20
Current report (foreign)
7:03pm
6-K
EX-99.2
knkkyzb
17 Jul 20
Invitation to the Annual General Meeting
9:58am
6-K
ocot2n
6 May 20
Current report (foreign)
3:55pm
6-K
EX-99.1
j2sn5xfp
29 Oct 19
Current report (foreign)
12:14pm
6-K
EX-99.1
yxs4qbx27laj4k
11 Jul 19
Current report (foreign)
8:40am
6-K
EX-99.1
mx6mxcn 4x4
10 Apr 19
Annual General Meeting
7:56am
6-K
EX-99.1
c2y3p1bjmhphv7xbba
12 Jun 18
Current report (foreign)
1:31pm